Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease [Phase 4]
Phase 4 trial comparing dabigatran to conventional treatment for preventing silent cerebral infarcts in patients with atrial fibrillation an…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF) [NA]
This clinical trial evaluated the safety and effectiveness of the STSF Catheter for treating symptomatic persistent atrial fibrillation. The…
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
Clinical trial update for the GLORIA-AF Registry Program (Phase II/III) in EU/EEA showing completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation [Phase 4]
A Phase 4 trial evaluating anticoagulation therapy in hemodialysis patients with atrial fibrillation has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation [NA]
This clinical trial update summarizes completed results for the DiamondTemp ablation system in treating paroxysmal atrial fibrillation, with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-11-30FDA Approved: DOFETILIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application from Aurobindo Pharma Limited to manufacture and market dofetilide as a generic drug.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Study of DU-176b Aged 80 Years or Older [Phase 3]
Phase 3 clinical trial update for DU-176b in adults 80 years or older with atrial fibrillation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS) [NA]
Completed trial update on arrhythmia detection in obstructive sleep apnea (ADIOS) with results posted.
-
FDA approval · 2020-11-16FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for Multaq (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2020-11-12FDA Approved: DIGOXIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Digoxin submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation [Phase 2]
A Phase 2 study evaluating ranolazine and dronedarone, alone and in combination, in patients with paroxysmal atrial fibrillation; the trial …
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation [NA]
Clinical trial update on adjunctive renal denervation for atrial fibrillation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Oral Anticoagulation in Hemodialysis [Phase 4]
Phase 4 trial update on oral anticoagulation in patients with atrial fibrillation undergoing hemodialysis.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification [Phase 4]
Phase 4 trial comparing rivaroxaban to vitamin K antagonists in patients requiring long-term anticoagulation with cardiovascular calcificati…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial [NA]
A completed clinical trial evaluating intravenous magnesium infusion during cardioversion in patients with atrial fibrillation; results have…
-
CLINICAL_TRIALS research · 2020-10-20Clinical Trial Update: Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias [NA]
Clinical trial evaluating Apple Watch features for identifying cardiac arrhythmias has completed with results posted.
-
FDA approval · 2020-10-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
The FDA approved the original application for Verapamil hydrochloride from Sagent Pharmaceuticals, establishing a generic version of this ca…
-
FDA approval · 2020-10-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for Verapamil hydrochloride from Zydus Pharmaceuticals USA Inc., confirming the generic formulation of…
-
FDA approval · 2020-10-07FDA Approved: DIGOXIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for digoxin filed by Sun Pharmaceutical Industries, Inc. to update the drug's labeling.
-
FDA approval · 2020-10-07FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for digoxin submitted by Hikma Pharmaceuticals USA Inc., authorizing changes to the product as r…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation [NA]
Clinical trial completed; study on endocardial ablation system for paroxysmal atrial fibrillation has posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Integrated Management Program Advancing Community Treatment of Atrial Fibrillation [NA]
A completed clinical trial update on an integrated management program for community treatment of atrial fibrillation, with results posted in…
-
FDA approval · 2020-09-16FDA Approved: FLECAINIDE ACETATE — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved flecainide acetate from Unichem Pharmaceuticals (USA), Inc. as an original ANDA (210683) for the treatment of documented tachya…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation [Phase 4]
Phase 4 trial update on antithrombotic therapy in patients with atrial fibrillation after successful ablation has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: STOP Persistent AF [NA]
The STOP Persistent AF trial has completed and results were posted on 2020-08-21.